WINDUVEO
Dead / Abandoned — Abandoned — no statement of use filed (as of 14 Sept 2026)
What this means for you
This application is over — abandoned 14 Sept 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 99256139
- Mark type
- Stylized text
- Filed
- 27 Jun 2025
- Published for opposition
- 16 Dec 2025
- Abandoned
- 14 Sept 2026
- Attorney of record
- Xiomara Triana
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes
Owner
- Bristol-Myers Squibb Company, Princeton, NJ, US
- Bristol-Myers Squibb Company, Princeton, NJ, US
Prosecution history
- 14 Sept 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 14 Sept 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 10 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Dec 2025 — PUBLISHED FOR OPPOSITION
- 10 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Nov 2025 — ASSIGNED TO EXAMINER
- 05 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Jun 2025 — APPLICATION FILING RECEIPT MAILED
- 27 Jun 2025 — NEW APPLICATION ENTERED